Most patients were satisfied with topical finasteride, and few experienced side effects.
September 2025 in “JMIR Dermatology” Topical finasteride is well-tolerated and satisfies most users with minimal side effects.
14 citations
,
September 2023 in “The Medical Journal of Australia” Telemedicine in Australia is growing, but concerns about quality and integration with traditional care remain.
October 2022 in “International Journal of Dermatology” Digital health platforms improve treatment for male pattern hair loss.
7 citations
,
April 2022 in “Cutis” Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.